title: [Neuropeptide Y, ghrelin and leptin plasma levels in anorexia nervosa patients and their changes during six-week refeeding].
abstract: OBJECTIVE
  Anorexia nervosa (AN) is characterized by markedly changes in hormone secretion influencing food intake, energy homeostasis and long-term body weight regulation. The aim of this study was to determine neuropeptide Y (NPY), ghrelin and leptin plasma levels and their changes after six weeks of nutritional-rehabilitation program in severely malnourished anorexia nervosa patients.
  
  
  METHODS
  Ten women with DSM-IV diagnosed anorexia nervosa, hospitalized (BMI 14.74 +/- 0.43; age 23.3 +/- 1.0) and ten age-matched healthy women (BMI 21.45 +/- 0.72; age 24.3 +/- 0.8) were enrolled to the study. Fasting plasma levels of NPY, ghrelin and leptin were measured before and after the treatment.
  
  
  RESULTS
  Fasting plasma ghrelin and NPY levels were significantly increased in AN patients comparing to healthy women, while plasma leptin was decreased. After six weeks of the treatment plasma ghrelin levels significantly decreased and plasma leptin levels increased. Plasma NPY levels didn't change during the treatment, average BMI significantly increased in AN patients.
  
  
  CONCLUSIONS
  We confirmed that ghrelin and leptin plasma levels express actual nutritional status of a body and did change during the six-weeks refeeding in AN patients. Plasma leptin levels together with constantly increased NPY levels indicate to persisting dysregulation of appetite and body weight control mechanisms in AN patients.
authors: Laborator klinické a experimentální neuroendokrinologie Endokrinologického ústavu Praha.
authors: L
authors: L
authors: Beranová
authors: D
authors: D
authors: Sedlácková
authors: J
authors: J
authors: Kopecková
authors: V
authors: V
authors: Hainer
authors: H
authors: H
authors: Papezová
authors: H
authors: H
authors: Kvasnicková
authors: J
authors: J
authors: Nedvídková
mesh_terms: D000328:Adult; D000856:Anorexia Nervosa / Q000097:blood* / Q000178:diet therapy*; D005260:Female; D054439:Ghrelin / Q000097:blood*; D006801:Humans; D020738:Leptin / Q000097:blood*; D009478:Neuropeptide Y / Q000097:blood*; D055815:Young Adult
chemical_list: D054439:Ghrelin; D020738:Leptin; D009478:Neuropeptide Y